BIIB
BIOGEN INC.Data updated: 2026-06-05 · Current price: $195.34
Composite Score: 61
HOLD
Score: 61 / 100
Valuation is within reasonable range — hold and wait for a better entry point
Profitability
53
Growth
45
Valuation
40
Moat
26
Stability
93
Business Quality
ROE · Gross Margin · Revenue Growth
ROE
7.1%
Quality threshold: > 15%
Gross Margin
75.7%
Quality threshold: > 40%
Rev. Growth (5yr)
0.0%
Quality threshold: > 5%
5-Year ROE: 7.1% → 9.8% → 7.8% → 22.8% → 14.2%|5-Year Gross Margin: 75.7% → 76.1% → 74.2% → 77.6% → 80.8%
Financial Strength
Debt Ratio · Free Cash Flow · Current Ratio
Debt / Equity
0.61
Quality threshold: < 0.5
FCF (5yr avg)
2.5B $
Quality threshold: > 0
Current Ratio
2.63x
Quality threshold: > 1.5
FCF Trend (B USD)
$2.4B2022
$3.0B2023
$1.8B2024
$1.6B2025
$3.9B2026
Valuation
Intrinsic Value · Margin of Safety
Owner Earnings
$1.9B
Net Income + D&A - CapEx
Current Price
$195.34
Source: Alpha Vantage
💡 Valuation Note: Intrinsic value based on DCF model, adjustable above. Visit the DCF Calculator for full three-stage valuation.
Complete Your Analysis
"Price is what you pay. Value is what you get."
— Warren Buffett